Use of an electronic metabolic monitoring form in a mental health service – a retrospective file audit

[1] De Hert M(2011)Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care World psychiatry 10 52-77

[2] Correll CU(2004)Prevalence, severity, and co-occurrence of chronic physical health problems of persons with serious mental illness Psychiatr Serv 55 1250-1257

[3] Bobes J(2015)Mortality in mental disorders and global disease burden implications: A systematic review and meta-analysis JAMA Psychiatry 72 334-341

[4] Cetkovich-Bakmas M(2011)The high prevalence of poor physical health and unhealthy lifestyle behaviours in individuals with severe mental illness Issues Ment Health Nurs 32 589-597

[5] Cohen D(2013)Metabolic syndrome and metabolic abnormalities in bipolar disorder: A meta-analysis of prevalence rates and moderators Am J Psychiatry 170 265-274

[6] Asai I(2004)North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes Diabetes Care 27 596-601

[7] Jones D(2000)Cardiovascular adverse effects of antipsychotic drugs Drug Saf 23 215-228

[8] Macias C(2012)Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: Systematic review and meta-analysis of screening practices Psychol Med 42 125-147

[9] Barreira P(2015)Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications Early Interv Psychiatry 44 457-466

[10] Fisher W(2015)The prevention of diabetes and cardiovascular disease in people with schizophrenia Acta Psychiatr Scand 45 824-829

[1] De Hert M(2011)Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care World psychiatry 10 52-77

[2] Correll CU(2004)Prevalence, severity, and co-occurrence of chronic physical health problems of persons with serious mental illness Psychiatr Serv 55 1250-1257

[3] Bobes J(2015)Mortality in mental disorders and global disease burden implications: A systematic review and meta-analysis JAMA Psychiatry 72 334-341

[4] Cetkovich-Bakmas M(2011)The high prevalence of poor physical health and unhealthy lifestyle behaviours in individuals with severe mental illness Issues Ment Health Nurs 32 589-597

[5] Cohen D(2013)Metabolic syndrome and metabolic abnormalities in bipolar disorder: A meta-analysis of prevalence rates and moderators Am J Psychiatry 170 265-274

[6] Asai I(2004)North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes Diabetes Care 27 596-601

[7] Jones D(2000)Cardiovascular adverse effects of antipsychotic drugs Drug Saf 23 215-228

[8] Macias C(2012)Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: Systematic review and meta-analysis of screening practices Psychol Med 42 125-147

[9] Barreira P(2015)Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications Early Interv Psychiatry 44 457-466

[10] Fisher W(2015)The prevention of diabetes and cardiovascular disease in people with schizophrenia Acta Psychiatr Scand 45 824-829